Skip to content

Investigator

Tod Ramses Ibrahim

AMERICAN SOCIETY OF NEPHROLOGY, INC. · funded by NIDDK, FDA

Companies
2

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$427k

Summed across those awards.

First award
Sep 1, 2014

Latest May 4, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R13

    Acute Kidney Injury: From Bench to Bedside

    $15k

    May 4, 2025NIDDKAMERICAN SOCIETY OF NEPHROLOGY, INC.NIH RePORTER · 11168417 (opens the source filing in a new tab)

  2. R25

    Fostering Innovative Leaders in Nephrology and Dialysis (FIND)

    $112k

    Sep 1, 2023NIDDKAMERICAN SOCIETY OF NEPHROLOGY, INC.NIH RePORTER · 11456031 (opens the source filing in a new tab)

  3. R18

    Kidney Health Initiative is a public-private partnership between the American Society of Nephrology, US Food and Drug Administration and the kidney community.

    $300k

    Sep 1, 2014FDAAMERICAN SOCIETY OF NEPHROLOGY, INC.NIH RePORTER · 11194514 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources